PDCD1 and neoplasm: Regardless of Anti‐IgG or Anti‐PD‐1 treatment, Anta‐137463 treatment increased the staining level of INSIG1 and reduced the level of SREBP2 in serial sections of xenograft tumor tissues (Figure 7F).